At last, correlation analysis demonstrated that these four chemicals are associated with the reduction of serum NT-proBNP, and their suitable pharmacokinetic characteristics make them have the potential to be the pharmacodynamic substances in the treatment of CHF-HKYd. Here, NPPB is linked to congestive heart failure.